諾瓦瓦克斯公司
MX ˙ BMV ˙ US6700024010
SecurityMX:NVAX / Novavax, Inc.
InstitutionUs Bancorp \de\
Latest Disclosed Ownership13,170 shares
Latest Disclosed Value $ 107,204
Us Bancorp \de\ reports 1.99% increase in ownership of NVAX / Novavax, Inc.

On May 14, 2026 - Us Bancorp \de\ filed a 13F-HR form disclosing ownership of 13,170 shares of Novavax, Inc. (MX:NVAX) valued at $107,204 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 30, 2026 disclosing 12,913 shares of Novavax, Inc.. This represents a change in shares of 1.99% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F NOVAVAX COM NEW 670002401 13,170 257 1.99 107 24.42 0.0001
2026-01-30 2025-12-31 13F NOVAVAX COM NEW 670002401 12,913 -419 -3.14 87 -25.22 0.0001
2025-11-12 2025-09-30 13F NOVAVAX COM NEW 670002401 13,332 -1,152 -7.95 116 26.37 0.0001
2025-07-24 2025-06-30 13F NOVAVAX COM NEW 670002401 14,484 2,433 20.19 91 18.18 0.0001
2025-05-08 2025-03-31 13F NOVAVAX COM NEW 670002401 12,051 245 2.08 77 -18.09 0.0001
2025-02-05 2024-12-31 13F NOVAVAX COM NEW 670002401 11,806 -493 -4.01 95 -39.35 0.0001
2024-10-28 2024-09-30 13F NOVAVAX COM NEW 670002401 12,299 11,961 3,538.76 155 3,775.00 0.0002
2024-08-07 2024-06-30 13F NOVAVAX COM NEW 670002401 338 -1,480 -81.41 4 -50.00 0.0000
2024-05-08 2024-03-31 13F NOVAVAX COM NEW 670002401 1,818 623 52.13 9 60.00 0.0000
2024-02-09 2023-12-31 13F NOVAVAX COM NEW 670002401 1,195 -4,726 -79.82 6 -88.10 0.0000
2023-11-03 2023-09-30 13F NOVAVAX COM NEW 670002401 5,921 -2,645 -30.88 43 -33.33 0.0001
2023-08-10 2023-06-30 13F NOVAVAX COM NEW 670002401 8,566 3,626 73.40 64 85.29 0.0001
2023-05-09 2023-03-31 13F NOVAVAX COMMON STOCK 670002401 4,940 2,755 126.09 34 54.55 0.0001
2023-02-13 2022-12-31 13F NOVAVAX COMMON STOCK 670002401 2,185 -469 -17.67 22 -55.10 0.0000
2022-10-27 2022-09-30 13F NOVAVAX COMMON STOCK 670002401 2,654 384 16.92 49 -58.12 0.0001
2022-08-01 2022-06-30 13F NOVAVAX COMMON STOCK 670002401 2,270 187 8.98 117 -24.03 0.0002
2022-05-11 2022-03-31 13F NOVAVAX COMMON STOCK 670002401 2,083 614 41.80 154 -27.01 0.0003
2022-02-11 2021-12-31 13F NOVAVAX COMMON STOCK 670002401 1,469 -556 -27.46 211 -49.64 0.0003
2021-11-10 2021-09-30 13F NOVAVAX COMMON STOCK 670002401 2,025 -93 -4.39 419 -6.68 0.0008
2021-08-05 2021-06-30 13F NOVAVAX COMMON STOCK 670002401 2,118 -2,730 -56.31 449 -48.92 0.0008
2021-04-28 2021-03-31 13F NOVAVAX COMMON STOCK 670002401 4,848 -1,858 -27.71 879 17.51 0.0018
2021-02-04 2020-12-31 13F NOVAVAX COMMON STOCK 670002401 6,706 1,032 18.19 748 21.63 0.0016
2020-11-10 2020-09-30 13F NOVAVAX COMMON STOCK 670002401 5,674 2,017 55.15 615 101.64 0.0015
2020-08-07 2020-06-30 13F NOVAVAX COMMON STOCK 670002401 3,657 3,257 814.25 305 6,000.00 0.0008
2020-05-13 2020-03-31 13F NAVAVAX COMMON STOCK 670002401 400 -503 -55.70 5 150.00 0.0000
2016-11-04 2016-09-30 13F NOVAVAX COMMON STOCK 670002104 903 0 0.00 2 -71.43 0.0000
2016-08-10 2016-06-30 13F NOVAVAX COMMON STOCK 670002104 903 0 0.00 7 40.00 0.0000
2016-05-13 2016-03-31 13F NOVAVAX COMMON STOCK 670002104 903 0 0.00 5 -37.50 0.0000
2016-02-10 2015-12-31 13F NOVAVAX COMMON STOCK 670002104 903 0 0.00 8 33.33 0.0000
2015-11-16 2015-09-30 13F NOVAVAX COMMON STOCK 670002104 903 -880 -49.36 6 -70.00 0.0000
2015-08-10 2015-06-30 13F NOVAVAX COMMON STOCK 670002104 1,783 -2,621 -59.51 20 -44.44 0.0001
2015-05-08 2015-03-31 13F NOVAVAX COMMON STOCK 670002104 4,404 0 0.00 36 38.46 0.0001
2015-02-13 2014-12-31 13F NOVAVAX COMMON STOCK 670002104 4,404 -1,949 -30.68 26 0.00 0.0001
2014-11-14 2014-09-30 13F NOVAVAX COMMON STOCK 670002104 6,353 0 0.00 26 -10.34 0.0001
2014-08-14 2014-06-30 13F NOVAVAX COMMON STOCK 670002104 6,353 0 0.00 29 0.00 0.0001
2014-05-14 2014-03-31 13F NOVAVAX COMMON STOCK 670002104 6,353 -3,127 -32.99 29 -40.82 0.0001
2014-02-13 2013-12-31 13F NOVAVAX COMMON STOCK 670002104 9,480 -3,038 -24.27 49 25.64 0.0002
2013-11-07 2013-09-30 13F NOVAVAX COMMON STOCK 670002104 12,518 0 0.00 39 50.00 0.0002
2013-08-09 2013-06-30 13F NOVAVAX COMMON STOCK 670002104 12,518 12,518 26 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.